Abstract: This review focuses on utilization of plant lectins as medical diagnostic reagents and tools. The lectin-related diagnostic is aimed at detection of several diseases connected to alteration of the glycosylation profiles of cells and at identification of microbial and viral agents in clinical microbiology. Certain lectins, proposed for or used as diagnostic tools could even recognize those cellular determinants, which are not detected by available antibodies. Broad information is presented on the lectinomics field, illustrating that lectin diagnostics might become practical alternative to antibody-based diagnostic products. In addition, the rising trend of lectin utilization in biomedical diagnostics might initiate a development of innovative methods based on better analytical technologies. Lectin microarray, a rapid and simple methodology, can be viewed as an example for such initiative. This technology could provide simple and efficient screening tools for analysis of glycosylation patterns in biological samples (cellular extracts, tissues and the whole cells), allowing thus personalized detection of changes associated with carbohydrate-related diseases.
Introduction
Carbohydrates, in forms of glycoproteins, glycolipids and polysaccharides are important signaling molecules. Sugar-based modifications are not only found on cell surface (as for example the blood cells and viral HIV glycans), but also present on most plasma membrane and secretory proteins. Carbohydrates have great potential to encode biological information and may therefore act as recognition determinants in a variety of physiological and pathological processes (Sharon & Lis 1993) . Glycans, as potential biomarkers for several diseases, caught attention also in clinical proteomics (Wuhrer 2007) . Not surprisingly, aberrant glycosylation is observed in a variety of diseased conditions (Varki, 1999) , including hereditary disorders (Durand & Seta 2000) , cancer (Dennis et al. 1999; Dube & Bertozzi 2005; Fuster & Esko 2005) , immunodeficiency (Ji et al. 2006) , neurodegeneration and diabetes (Hart et al. 2007 ). Experimental approaches have been developed for biochemical analysis of patient samples; these are either based on measurements of changes in activity levels of enzymes responsible for particular glycan synthesis and/or the alterations in cell-surface oligosaccharide structures (Durand & Seta 2000; Schulz et al. 2007) .
Lectins are proteins that specifically bind carbohydrates, of either mono-or oligosaccharide structures. Examples of lectin's high specificity for glycan ligands include prototypical plant lectins like concanavalin A (Con A) which recognizes mannose and glucose (Man/Glc), wheat germ agglutinin (WGA) that recognizes N-acetylglucosamine (GlcNAc) and Nacetylneuraminic acid (Neu5Ac), soybean agglutinin (SBA) specific for galactose (Gal) and N-acetylgalactosamine (GalNAc), and ricin (RCA) that recognize Gal (Fig. 1 ). While some highly conserved amino acid residues present in the binding site provide the basis for carbohydrate-lectin interactions, the specificity of binding is proposed to arise from a variability of amino acids within the other regions of carbohydrate-binding site (Ambrosi et al. 2005) . Furthermore, the association constants of lectins for di-, tri-and tetrasaccharides are significantly higher than for corresponding monosaccharides (Ambrosi et al. 2005) . Comprehensive information 2 D. Mislovičová et al. (Discovery Studio Visualizer, v2.0, 2007) ; (courtesy of Accelrys, Inc.). The X-ray structures of concanavalin A (Con A) (Naismith et al. 1994) , wheat germ agglutinin (WGA) (Schwefel et al. 2008) , soybean agglutinin (SBA) (Olsen et al. 1997 ) and ricin (Rutenber et al. 1991) are visualized in ribbon-like representation. The coordinates were downloaded from the Protein Data Bank (PDB; http://www.rscb.org/). The corresponding PDB codes used for visualization are in blue. The color coding is either according to molecular chains, or reflecting the N to C terminal domains; all glycan structures are in orange. The lectin-saccharide interactions pattern is highlighted for SBA, together with the calcium and manganese atoms displayed in the structure. All crystallographic water molecules were omitted.
on the binding strength (according the association K a and dissociation K d constant) of glycans to a panel of 120 lectins is provided in the very recent minireview of Hirabayashi (Hirabayashi 2008) . The author describes the critical issues of using lectins, either alone, or in comparison to antibodies, in view of frontal affinity chromatography (FAC) and lectin microarray data.
Structurally, plant lectins (particularly legume lectins, the largest (around hundred members) and most studied family of simple lectins) consist of two (dimer) or four (tetramer) identical or nearly identical subunits, thus containing two or more carbohydrate binding sites. Overall, these structural features of lectins are responsible for their ability to cause crosslinking of the cells and their subsequent precipitation. The erythrocyte agglutinating or hemagglutinating activity of lectins is their significant behavior utilized frequently for their detection and characterization (Lis & Sharon 1998) .
Ever since the original characterization of lectins ability to specifically bind cell surface oligosaccharides (and other forms of carbohydrates), their applications for basic research and routine biomedical diagnostics screens have become irreplaceable (Gabius & Gabius 1993; Rhodes & Milton 1998; Rudiger & Gabius 2001) . The applications of plant lectins to analyze the "glycocode" include, but are not limited to: (i) blood group typing and state of individual's immune system; (ii) detection of disease related alterations in presented glycoconjugates; (iii) alterations due to disease on-set and progression (i.e. cancer and metastasis); and (iv) detection and diagnosis of infectious agents (such as viruses, bacteria, parasites, fungi). All these applications are based on assessment of glycosylation profiles and/or carbohydrate structural changes which can be detected, quantified and characterized on a molecular level by plant lectins (Rudiger & Gabius 2001) . The outcomes of functional lectinomics (Gabius et al. 2002) facilitate the biomedical applications of lectins. Although the relevance of lectins in pathological conditions has been reviewed in detail (Caron & Seve 2000) , the "state of the art" methodologies available today initiated our interLectinomics I. Plant lectins in biomedical diagnostics 3 est to provide updated information on diagnostic application of lectins. This review and the consequent article (Gemeiner et al. 2008 ) are aimed to describe the current lectinomics achievements in the field of clinical diagnostic. The changes in the glycosylation profiles due to disease and infection, as detected by lectin-based assays in patient samples will further highlight the indispensable uniqueness of exogenous lectins as prognostic and diagnostic tools.
Laboratory techniques in lectin diagnostics
Numerous methods have been adapted to study and characterize lectin-glycan binding profiles. The challenges related to analyze glycans in biological samples include (but are not limited to) heterogeneity of modifications and low abundance (thus the requirement for enrichment). In order to study lectin-carbohydrate interactions, lectin modifications are required, either by binding biotin or fluorescent dyes covalently, or by adding gold particles. Such modifications facilitate consequent detection of lectin-carbohydrate binding profiles, using immunohistochemistry (immunocytochemistry), lectin-blotting and enzyme-linked lectin assays (Lis & Sharon 1998) . Additionally, lectins attached to solid support (such beads) are indispensable for affinity chromatography, which can be employed as series of columns, so called serial lectin affinity chromatography (SLAC). A newer method to study lectin-carbohydrate interactions takes advantage of an array format and has been discussed elsewhere (Gemeiner et al. 2008) . Furthermore, mass spectrometry provides unambiguous identification of the residue modified by glycosylation and the carbohydrate structures (Satish & Surolia 2001; Zhao et al. 2006) . Lectin-based methodologies will be briefly introduced with examples of applications to study patient samples. Figure 2 represents examples of equipments for methodologies described above together with the corresponding printouts.
Quantitative precipitation/agglutination method The specificity of interactions between glycoconjugates and lectins is the driving force for formation of precipitates/agglutinates. Agglutination can be investigated in samples that contain high concentration of carbohydrates; these can be either on cell surface or in biological fluids. The specificity of carbohydrate-lectin binding can be monitored by inhibition tests of agglutination activity by lectins and saccharide epitopes (Basu et al. 2003; Munoz et al. 2003) . For example, changes in prostate-specific antigen glycosylation from patient serum after binding to Con A can be used as preliminary discriminatory tool between benign prostatic hyperplasia and prostate cancer, prior to more invasive biopsy (Basu et al. 2003) .
Histo-and cytochemical methods
The basis of these methods is visual detection of carbohydrates in tissues (for example tissue biopsy) and/or on cell surfaces with specifically labeled lectins. The histochemical "why and how to detect lectin localization" is well-reviewed by Gabius (2001) ; further examples for probing and visualizing carbohydrates are available in recent literature (Konska et al. 2005; Arab et al. 2006; Babal et al. 2006 ).
Enzyme-linked lectin assays (ELLA)
ELLA is a method comparable to the enzyme-linked immunosorbent assay (ELISA). ELLA is based on binding of biotinyled lectins to glycoconjugates immobilized on a microtiter plate. The bound lectins are detected with labeled avidin (streptavidin) (Duk et al. 1994; Orntoft et al. 1997; Kratz et al. 2003) . This experimental approach was used to characterize T-antigen levels (Reddi et al. 2000) . Briefly, wells were coated with serum from patients and healthy controls, and then incubated with PNA lectin. PNA was detected by antibody against lectin (rabbit), which was in turn recognized by anti-rabbit secondary antibody coupled to HRP (horse-radish peroxidase), allowing thus calorimetric detection consequently. The results of this study indicated increased levels of PNA-binding antigens in patient serum (stages II to IV) in comparison to healthy controls (Reddi et al. 2000) .
Lectin affinity chromatography (LAC)
LAC is based on fractionation of sample through numerous affinity chromatography columns containing immobilized lectins, thus specific carbohydrate containing structures either bind or pass through these affinity columns. The order of the affinity purification affects the composition of enriched sample and combinations include (but are not limited) for example Con A and phytohaemagglutinin E column, Con A and pea lectin (PSA) or WGA columns (Yoshida et al. 1995 (Yoshida et al. , 1997 Sumi et al. 1999) . Recently, this experimental approach was further expanded to identify sialylated glycoprotein markers in serum of pancreatic cancer patients (Zhao et al. 2006) . Unambiguous protein identification, glycopeptides mapping and identification of glycan structures can be performed by mass spectroscopy (Zhao et al. 2006 ).
Lectin blotting
Lectin blotting is a modified version of western blotting/immunoblotting approach, adapted to study carbohydrate modifications on proteins. Labeled lectins can be used to detect sugar groups present on the blot in glycoconjugate mixtures, electrophoretically separated glycoconjugates and transferred to a nitrocellulose membrane (Turner 1992; Youings et al. 1996; Krzeslak et al. 2003; Kotani et al. 2004; Przybylo et al. 2005) . Although this is a qualitative method, it can be used to detect the lectin binding moieties in mixtures (Wu et al. 2008 ).
Crossed affinity-immunoelectrophoresis (CAIE) CAIE was originally developed by Bog-Hansen (1973 , 1977 and is a two-dimensional electrophoretic proce- dure. CAIE is based on changes in migration pattern of a glycosylated protein in agarose gel, which contains an embedded lectin (like Con A). The separation into different glycoforms is dependent on the affinity of the sugar for this lectin. Thereafter, separation in a second dimension is performed, and in this case, antibodies specific for the protein of interest are embedded into the gel. The complex formation is visualized by Coomassie Blue staining (Kratz et al. 2003) .
Flow cytometry
Flow cytometry is a new technique for counting, examining and sorting microscopic particles suspended in a stream of fluid. Fluorescein isothiocyanate (FITC)-labeled lectins are used for determination of cell surface glycoconjugates. All suspended particles scatter the light, whereas the FITC labeled particles are excited into emitting light at higher wavelength than the light source. (Heyder et al. 2003; Yamamoto et al. 2005; Jenner et al. 2006) .
Surface plasmon resonance (SPR)
This technique allows one to determine the binding selectivity and characteristics of carbohydrate structures to lectin immobilized on a biosensor surface. Briefly, the lectin is first attached to a glass surface (optical biosensors) through a number of alternative surface chemistries and then the measurements of carbohydrate content in solution are monitored as changes in the refractive index (Liljeblad et al. 2000 (Liljeblad et al. , 2002 Krotkiewska et al. 2002 Krotkiewska et al. , 2005 Jelinek & Kolusheva 2004) . SPR was for example used to discriminate glycosylation pattern of IgG in rheumatoid arthritis patients, where the galactosylation is decreased causing an increase in terminal N-acetylglucosamine residue, detectable by lectin from Psathyrella velutina (Liljeblad et al. 2000) .
Application of plant lectins as diagnostic tools
A potential diagnostic use of lectins involves the determination of glycan changes in human tissues, cells, serum and other physiological fluids. Schultz et al. (2007) reviewed the clinical laboratory tests related on detection of glycoconjugates. The focus of this review is to highlight the advantages of plant lectins as diagnostic tools. Their stability, availability and other advantages over other biomacromolecules will be addressed. Lectins described in this review are summarized in Table 1 . We will concentrate in the forthcoming paragraphs on four important diagnostic areas (see interrelation scheme in Figure 3 ) of plant lectins in medical research and diagnostics.
Application of lectins in clinical microbiology and virology
Lectins are indispensable tools for detections of microbes. For example, the lectin-based optical biosensor approach has been utilized to detect pathogenic bacteria (Masarova et al. 2004 ). The advantage of lectins over monoclonal antibodies in this experimental setting includes their commercial availability and stability in standard buffers.
Lectin-derivatized surfaces can be used to capture and concentrate complex glycans and microorganism in order to analyze them consecutively by mass spectrom- etry (Bundy & Fenselau 2001) . This method was used to analyze representative samples from a wide variety of microorganisms of importance to human health, and also enveloped viruses. Bacterial samples were detected from physiological buffers, urine and milk using the biocapture probes. Viral samples were detected from cultures based on glycoprotein moieties captured directly from the surface (Bundy & Fenselau 2001) .
The nature of lectin receptors on microbial-viral surfaces is determined by combination of factors such as carbohydrate residues, hydrophobicity, and accessibility. Lectins are useful for characterization of bacterial cell components and for detection of bacteriophage receptors (Lis & Sharon 1986; Sharon & Lis 1989; Kennedy et al. 1995) . They have a role in the clinical laboratory identification and taxonomic classification of many microorganisms, in addition to epidemiological monitoring of microbial and viral agents. Concurrently, Slifkin (Slifkin & Doyle 1990 ) illustrated that agglutination technique and the Con A were predominantly used in the reviewed lectin diagnostic applications.
The lectin agglutination method was used in epidemiological and ecological studies of Streptococcus milleri (Kellens et al. 1994) .
Furthermore, this method was expanded to use thirty-two commercially available lectins. This array of lectins was subjected to agglutination study of seventyseven clinical isolates from methicillin-resistant Staphylococcus aureus (cultured on three different media). The result indicated that only five isolates were agglutinated by the same specific lectins set, regardless on the culture media used. Such lectin typing of Staphylococcus aureus could be thus turned into useful epidemiological tool (Munoz et al. 1999) .
Agglutination method involving a panel of plant lectins (AAA, ECA, LTA, UEA I, and WGA) was used to analyze differentiated Helicobacter pyroli strains (Hynes et al. 1999) This typing system was applied to a large number of Helicobacter isolates from different Table 1 . List of exogenous lectins either proposed become or used as diagnostic tools.
Systematic name
Origin of lectin Abbreviation Specificity
Coral tree seeds ECA Gal β (1-4)Gal NAc
Euonymus europaeus
Coral tree seeds
Phaseolus vulgaris
Red kidney bean
Wisteria floribunda seed WFA α, β-GalNAc a Origin other than plant. See "BIOCOMPARE -The buyers guide for life sciences" for the market availability of the lectin of interest; http://www.biocompare.com/.
geographical locations (Heneghan et al. 2000; . The data obtained showed that lectin typing is an effective method for epidemiological studies.
More recently, applications of plant lectins in clinical microbiology have expanded into new areas and are summarized below. The legume lectins (Con A, Con Br, DVL, DGL, CFL and VML) were investigated (in vitro) for their potential to detect and inhibit the adherence of five Streptococci species to enamel acquired pellicle (Teixeira et al. 2006) . Fluorescence micrography was employed to visualize the ability of these lectins labeled with FITC to attach to the pellicle carbohydrates and glycoproteins. If modified to fit clinical diagnostic settings, this experimental method might be applied for control of diseases associated with microbial colonization of teeth (Teixeira et al. 2006) . Figure 4 shows the affinity of saliva Streptococci to lectins by fluorescence microscopy test. The DSA, RPA and DBA lectins were found to be specific for the "large colony type" Streptococci of group C.
Lactobacillus isolates (six species) from healthy children were characterized by a lectin typing technique. An agglutination assay with a panel of six commercially available lectins supplements current molecular typing techniques and helps to identify Lactobacillus strains that could be important in bacteria for probiotics (Annuk et al. 2001) .
The typing of Staphylococcus epidermidis was investigated using the ELLA method, where four biotinylated lectins WGA, SBA, LCA and Con A were added to immobilized whole coagulase-negative staphylococci cells in microtitration plates. The assay was reproducible, easy to perform, relatively inexpensive, and is therefore applicable to large scale typing of Staphylococcus epidermidis (Jarlov et al. 1992) .
Suggestions have been made about the possible employment of the agglutinins Hypoxis hemerocallidea and Combretum mkhuzense from medicinal plants in clinical microbiology (Gaidamashvili & van Staden 2002) . Two gram-positive bacterial strains, Staphylococcus aureus and Bacillus subtilis can interact with plant agglutinins from indigenous South African medicinal plants (Hutchings et al. 1996 ).
An optimized lectin typing system for Campylobacter concisus strains from gingival pocked of patients after proteolytical pretreatment has been developed. Lectin typing was carried out by slide agglutination and microtiter well assays. Four lectins (BPA, Con A, ECA, and STA) were used to group the examined strains into 13 lectin reaction patterns. Lectin types were both stable and reproducible (Aabenhus et al. 2002) .
Agglutination in microbacterial plates was used in order to differentiate between mycobacterial species. Eighteen mycobacterial species were used to determine the minimal lectin concentration necessary for detection with twenty-three different lectins. In most cases, two lectins were sufficient to differentiate Mycobacteria species from one another; moreover, this was achieved for only twelve out of the twenty-three lectins employed. Lectins labeled with chromogenic reagents can be applied to detect and differentiate Mycobacteria species in clinical specimens (Athamna et al. 2006) .
A rapid, accurate and inexpensive hemagglutination assay was developed to diagnose Indian visceral leishmaniasis using achatinin H , a 9-O-acetylated sialic acid binding lectin. 9-O-AcSA is absent in normal erythrocytes, but detection with a lectin agglutination test showed that it can be used as an important biomarker reflecting indirectly the parasite presence (Sharma et al. 1998) . Metacyclogenesis in an axenic culture of Leishmania braziliensis, which is the causative agent of mucocutaneous leismaniasis in the New World, was characterized by negative agglutination with BPA lectin (Pinto-da-Silva et al. 2002) .
Various choanomastigote-shaped trypanosomatids (Crithidia and Herpetomonas sp.) were analyzed by Western blotting using the lectins LFA, SNA, and MAA, which specifically recognize sialic acid residues, and Con A, which recognizes mannose residues. The results obtained illustrated the heterogeneity of the genus Crithidia (d'Avila- Levy et al. 2004 ).
Lectin-affinity chromatography was developed for purification of MDCK cell culture derived human influenza A viruses using the Gal-specific ECAand EUA lectins. The EUA lectin exhibited the most specific binding according hemagglutination tests (Opitz et al. 2007 ).
Human immunodeficiency virus (HIV) can also be detected by plant lectins. Balzarini et al. (2004) investigated the interaction of HIV with mannosespecific plant lectins, and found that lectins from the Amaryllidaceae family (e.g., Hippeastrum sp. hybrid HHL and GNA) inhibit HIV infection of human lymphocytic cells (Balzarini et al. 2004 ; Turville et al. The MAA and SNA lectins were applied for determination of sialylation of the Herpes simplex virus type 1 (HSV-1) envelope. The ELLA method was used to discover that sialic acid plays an important role in HSV infection and may be a valid target for antiviral drug development (Ziolkowska & Wlodawer 2006) .
Detection of blood groups and erythrocyte recognition
The three types of blood-group antigens differ slightly in carbohydrate composition (see Figure 5 for details), which can be recognized either by antibodies (produced by immune system or commercially by hybridoma cell lines) or lectins (Schenkel-Brunner 2000) . The clinical blood group determination is based on the presence of specific sugars on erythrocyte surfaces. This specificity further highlights the potential role of carbohydrates as identity markers (Morgan & Watkins 2000) .
The sensitivity of lectins to recognize blood group antigens is comparable to antibodies (Matsui et al. 2001) . Several lectins, e.g., DBA, VVA, LBA, SBA and HPA recognize the A substance in the ABO blood group using the hemaaglutination method (Matsui et al. 2001; Sharon & Lis 2004) . Lectins GS-I (B 4 ) and UEA-I recognize blood group B-and 0(H) substances, respectively. The discrimination is based on the presence of the non-reducing αGal and αGalNAc terminals, whereas αFuc was defined as the only determinant of the H(0) blood group. The AAA, UEA-I and LTA lectins, recognize the same blood group (Morgan & Watkins, 2000; Matsui et al. 2001 ). The DBA lectin was used to distinguish blood subgroup A 1 from A 2 (Hoskins et al. 1995; Sharon & Lis 2004 ). The UEA-I lectin was used for detection of the H-substance and determination of secretor status (Rahat et al. 1990 ). Competitive hemagglutination studies with blood-groupspecific lectins reveal that WBA II lectin binds to H-and T-antigenic determinants on human erythrocytes (Patanjali et al. 1988 ). The binding specificities of ABO blood group-recognizing lectins were studied using numerous techniques including lectin-blotting analysis, enzyme linked immunosorbent assay and lectinconjugated agarose column chromatography (Matsui et al. 2001) .
Glycophorin A (GPA), is the major sialoglycoprotein of the human erythrocyte membrane (Lisowska 2001 ) and can be recognized by appropriate lectins. This was exploited in SPR analysis of glycophorin samples derived from individual human donors of defined ABO blood groups using the PVL, WGA and SBA lectins. The method was applied to analyze GPA samples derived from patients with defined diseases (Krotkiewska et al. 2002) .
One the best-known physiological processes initiated by protein-carbohydrate interactions is the clearance of old erythrocytes from the blood (Ambrosi et al. 2005) . Molecular mechanisms of erythrophagocytosis is based on desialylation of erythrocyte membrane glycoconjugates, which acts as a signal for red blood cell (RBC) capture by macrophages (Bratosin et al. 1995) . Flow cytometry using FITC labeled lectins was used to determine that aged erythrocytes bind less WGA, LPA, SNA and MAA than young erythrocytes (Bratosin et al. 1995 ). An immuno-electron microscopic method was used to evaluate the binding of WGA-gold conjugates to young and old human erythrocytes (Marikovsky & Marikovsky 2002) . It was estimated that WGA-gold conjugate binding to old erythrocytes was lower than to young erythrocytes, and that this was a consequence of loss of membrane surface sialic acid in old erythrocytes. Disease-diagnostics based on alterations of glycoconjugates
Lectins have a vast potential as reference tools for diagnosing various physiological situations and diseases. Table 2 summarizes the diagnostic capacity of lectins in relation for selected diseases. This section describes other than cancer-related diseases; review of cancer-initiated glycosylation changes/diagnostic follows. Chronic inflammation or rheumatic arthritis are typical diseases exhibiting glycosylation changes, thus lectins could be valuable detection tools. Glycosylation changes of transferrin in blood serum were detected in order to diagnose traumas and chronic inflammations (Sobiesiak 2002; Gornik & Lauc 2007 galactosylation and increased fucosylation of IgG by separation of IgG from human serum, followed by lectin blotting using Con A, RCA and LCA (Flogel et al. 1998; Tang et al. 1998; Ferens-Sieczkowska et al. 2007; Moldoveanu et al. 2007 ). Lectin-histochemical analysis was used to detect changes in sialylation in the thyroid gland. The MAA and SNA lectins helped to differentiate autoimmune disease from Hashimoto thyroiditis Jenner et al. 2006) . The lung tissues were used for histochemical determination (using the TML, SNA and MAA lectins) of sialic acid changes during intrauterine development of the human fetus , and for identification of sepsis-associated fatalities using a set of eleven lectins (Tsokos et al. 2002; Tsokos 2003) . The direct immunofluorescence reaction of human placenta tissues with the fluorescein-labeled (FITC) lectins WGA and LCA was used to study the effect of environmental pollution on placenta glycosylation (Konska et al. 2003 (Konska et al. , 2005 .
The abnormal fucosylation of infant ileal mucus in cystic fibrosis was identified by histochemical analysis using the LTG lectin. This method is useful in establishing a diagnosis in the neonatal period, when a sweat test is impractical (Thiru et al. 1990) .
Lectin diagnostic was also used to differentiate patients with active celiac disease, patients in remission and patients with other intestinal disorders. Light microscopy imaging allowed to analyze the differences in jejunal biopsy specimens due to different lectin binding specificities (Pittschieler et al. 1994 ).
Use of lectins in cancer research and diagnosis
The importance of lectins for cancer diagnostic is well recognized. Several studies demonstrated alterations of cell surface carbohydrates upon malignant transformation, tumor cell differentiation, and metastasis (Dennis et al. 1989; Hakomori 1989; Dennis 1992; Lu & Chaney 1993; Lu et al. 1994; Mody et al. 1995) . Modified glycosylation is a stamp for cancer development. Cancer cells frequently display glycans of different structures than those observed in normal cells. The tumor-associated carbohydrate antigens, which are most abundantly expressed antigens on the cell surface, can function as essential mediators of cell-cell recognition and cell adhesion, and serve as markers of differentiation and altered proliferation control (Singhal & Hakomori 1990; Sabri et al. 2000; Dube & Bertozzi 2005) . The lectins therefore have vital importance as diagnostic tools to monitor changes in glycosylation profiles that indicate malignancy.
Changes in carbohydrate composition (alteration of sialylation, branching, fucosylation and type and/or number of sugar residues) are applicable for cancer diagnostic and therapeutic purposes. The altered affinity to lectins and appearance of new glycoconjugates or modified level of existing glycoconjugates associated with disease progression can as well be detected by lectin diagnostics (Mody et al. 1995) .
Personalized detection of such changes, as associated with disease progression and responsiveness to treatment, could significantly improve treatment efficiency.
Estimation of glycosylation changes in cancer cells and tissues Alterations in glycosylation that indicating malignancy can be diagnosed from serum, or directly from tumor tissues or epithelium. Tumor-specific diagnostic methods require surgical biopsy followed by histological analysis with monoclonal antibodies or lectins. Alternatively, altered glycoproteins can also be isolated from tissues and analyzed by biochemical methods (Fischer et al. 1988; Krzeslak et al. 2003; Dube & Bertozzi 2005) .
N-linked glycan epitopes commonly found on transformed cells include sialyl Lewis x (sLe x ), sialyl Tn (sTn), GloboH, Lewis y (Le y ) and polysialic acid (Taylor-Papadimitriou & Epenetos 1994) . Many of these epitopes are observed in malignant tissues throughout the body including brain, breast, colon, prostate, ovary and lung (Orntoft & Vestergaard 1999) . Another common feature of tumors is the overproduction of certain glycoproteins and glycolipids. For example, mucin glycoproteins are overproduced in epithelial tumors, and therefore could serve as diagnostic markers (Hollingsworth & Swanson 2004) . Additionally, cancer tissues can display an increase in ganglioside expression, which has been observed in small-cell lung carcinomas, neuroblastomas and melanomas (Hakomori 2000) . The lectin based assays for detection of human cancer in tissues, cells and epithelia, are summarized in Table 3 .
The majority of lectins able to detect and characterize glycan epitopes in tissues and epithelium are specific for sialic acid, Fuc, GalNAc, Gal, GlcNAc and Man. The histochemical analysis of carcinomas with specific lectins often provides potentially important way to predict the invasive nature of malignant tumor cells. The HPA lectin was used to diagnose breast carcinomas (Arab et al. 2006 ) and the histochemical marker-based predictor for prognosis of lung-cancer. Dependent on the detection with HPA, patients with adenocarcinomas of the lung could be stratified into low and high risk groups (Laack et al. 2002) . HPA can help to indicate the high metastatic potential of lung primary tumors (Thom et al. 2007) , and colon and gastric carcinomas (Schumacher et al. 2005) . Example of lung cancer as detected by HPA histochemistry is presented in Figure  6 , which is reprinted from (Laack et al. 2002) .
The qualitative and quantitative differences in binding of Gal-specific lectins to cytosolic glycoproteins can distinguish benign and malignant tumors of human thyroid neoplasms (Krzeslak et al. 2003) . The lectin histochemistry (using Gal-and Fuc-specific lectins) of cystic jaw lesions was applied to differentiate between the diagnosis of cystic ameloblastoma and odontogenic cysts (Saku et al. 1991) . The sialic acid-specific lectins MAA, SNA and TML were eval-uated in lectin-histochemical detection of the thyroid gland cancer (increased α-2,3-linked sialic acid) (Babal et al. 2006 ) and head and neck squamaous cancer cells (suprabasal expression of α-2,3-linked sialic acid) (Chovanec et al. 2004) .
Serial lectin affinity chromatography was used to demonstrate altered asparagine-linked carbohydrate chain structures on certain enzymes and/or proteins from cancer patients. Gel columns containing lectins Con A, PHA-E, PHA-L, PSA and WGA were used to investigate γ-glutamyltransferase (GGT) in human renal cell carcinoma (RCC) (Yoshida et al. 1995) , to detect altered Asn-linked saccharide chain structure of prostatic acid phosphatase (Yoshida et al. 1997) and prostate-specific antigen . Alterations of Asn-linked saccharides on N-acetyl-β-Dhexosaminidase during renal oncogenesis were studied using serial lectin affinity chromatography with Con Aand WGA ). The leukemic T-cells derived from acute lymphoblastic leukemia and normal cells were separated by a DBA and SBA lectins, respectively, and analyzed by flow cytometry and fluorescent microscopy (Ohba et al. 2002; Bakalova & Ohba 2003) . Lectin affinity chromatography may become a new generation of methods applied to diagnostic research in leukemia.
One of the major problems which occur during the cancer treatment is the induction of cytostatic resistance, as accompanied by high expression of the mdr1 gene encoded plasma membrane glycoprotein, Pgp (Breier et al. 2005) . Pgp is responsible for decrease in the intracellular accumulation of cytotoxic substances, thus causing resistance to cancer drugs. Lectins may be used as a marker for the detection of Pgp-linked multidrug resistance. Experimental evidence suggests that over-expressed Pgp in MES-SA/Dx5 cells (human uterine sarcoma cell line) is altered by glycosylation, as detected by slab and preparative gel elution. Heavily glycosylated Pgp was recognized by specific lectins: high-mannose complex oligosaccharide with GNA, sialic acids with MAA and SNA, and Galβ-1,4-GlcNAc with DSA (Greer & Ivey 2007) . Ability to detect alterations in glycosylation on Pgp might provide a screening method for differentiation between Pgp-positive and Pgp-negative cells, thus identifying drug resistance.
Estimation of glycosylation changes in human serum
An alternative (or complementary) approach to analysis of tumor tissue is investigation of glycosylation changes in patient serum. Glycoproteins compose the major part of the serum proteome (Anderson & Anderson 2002) . Serum proteins like α-fetoprotein, haptoglobin, α-acidoglycoprotein, prostate specific antigen (PSa) and T-antigens, display changes in glycosylation in response to cancer. The individual serum glycoproteins have been analyzed using lectins to recognize the specific carbohydrate residues (Nilsson 2003; Xiong et al. 2003) .
The structure of α-fetoprotein's (AFP) carbohydrate chains slightly vary among AFP-producing tumors. Serum AFP is a useful marker for hepatoma (Wu 1990; Wang et al. 1996; Leerapun et al. 2007 ) and yolk sac tumor (Tanno et al. 1997) . When the AFP level is high, the co-existence hepatoma should be considered. Ability of lectins Con A and LCA to differentiate between heptocellular carcinoma and yolk sac tumors was analyzed from patient serum (Durand & Seta 2000) . Serum AFP is elevated in other tumors originating from stomach (Ooi et al. 1990 ), pancreas (Itoh et al. 1992) and lung (Yoshimoto et al. 1987) . Neoinfantile hepatic tumors and malignant germ cell tumors were detected by lectin reactive AFP (Kinoshita et al. 2008) . Additionally, it has been proposed that AFP level produced by pancreas carcinoma would be indicative of disease recurrence (Kawamoto et al. 1992; Tanno et al. 1997) . A mucus glycoprotein, which expresses the oncofetal antigen Gal-1,3-GalNAc (T blood group antigen), can be detected by PNA lectin from serum of pancreatic cancer patients (ELLA assay) (Ching & Rhodes 1989) . Another glycoprotein, PSa, can be used to detect changes in glycosylation during malignant transformation in serum samples. Serial lectin affinity chromatography (Con A, PHA-E4 and PHA-L4) of PSa and a quantitative precipitation of Con A-PSa, have been used to demonstrate the differences between prostate cancer (PCA) and benign prostatic hyperplasia (BPH), respectively Basu et al. 2003) . Lectin detection, glycosylation immunoabsorbant assay, and two-dimensional electrophoresis were used to compare the total glycoprotein profile in serum of prostatic cancer patient with those in normal serum. An increase in the proportion of sialyl-Lewis x structures in PCA patient serum was found (Tabares et al. 2006) . Different fucosylated forms of the β-chains of haptoglobins (FHp) were discovered in serum from patients with cancer and rheumatoid arthritis (Thompson & Turner 1987) . The ELLA method was used to rapidly detect FHp in cancer and rheumatoid sera in a quantitative manner (Thompson et al. 1989 ). This method was applied to quantify the T-antigen expression in the sera of patients with squamous cell carcinoma (SCC) of the uterine cervix. The degree of T-antigen interaction with PNA lectin may provide a useful biochemical indication for the clinical assessment of tumor spread and invasiveness of disease in SCC of the uterine cervix (Reddi et al. 2000) . The concentration of asialo-α 1 -acid glycoprotein (AsAGP) in human serum was measured by an antibody-lectin sandwich assay. This glycoprotein exhibited good diagnostic accuracy as a biomedical marker for liver cirrhosis (LC) and hepatocellular carcinoma (HCC).
Many assays, that utilize lectins to identify glycoprotein markers in serum from cancer patients rely on a three steps procedure: lectin affinity selection, separation and characterization of the glycoprotein markers by mass spectrometry (Drake et al. 2006; Madera et al. 2007) . Such methods were developed to determine extend of sialylated glycoproteins and N-linked glycosylation profiling in pancreatic cancer serum usLectinomics I. Plant lectins in biomedical diagnostics 13 ing WGA, SNA, MAA (Zhao et al. 2006 ) and enriched by Con A-affinity (Zhao et al. 2007a ). These glycoproteins were further fractionated by reversephase chromatography and characterized either directly, or after enzymatic cleavage by ESI-TOF MS (Electrospray ionization-of-flight mass spectrometry) and MALDI-QIT-TOF-MS (Matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight mass spectrometry). This strategy offers the ability to identify and quantitatively analyze changes in glycoprotein abundance and carbohydrate structures, and was used to analyze serum from PCA and HCC patients (Drake et al. 2006 ).
Estimation of glycosylation changes in physiological fluids
In addition to patient serum, the alterations of protein glycosylation can be detected from other physiological secretion products such as rectal mucus, bile duct in liver and urine. Accordingly, the combinations of WGA, PNA, and DBA lectins were used in ELLA assays in order to quantify specific glycan changes on glycoproteins that were obtained from human rectal mucus. SDS-PAGE and Western blotting with lectins were used to characterize glycoproteins. Correlative with cancer, an increase in PNA binding and reduction of DBA binding to rectal mucus glycoproteins immobilized on WGA, were observed (Orntoft et al. 1997) .
AFP, as already mentioned, and its fucosylated variant are highly specific tumor markers for hepatocellular carcinoma. Fucosylated AFP is secreted into the bile duct of the liver. Enhanced binding of biliary glycoproteins to lectins (AOL, AAL) that recognize fucose was observed over a wide range of molecular weights. The oligosaccharide structures on glycoproteins in human bile were compared with those in serum by several types of lectin blot analyses. It was suggested that fucosylation is a possible signal for the secretion of glycoproteins into bile ducts in the liver (Nakagawa et al. 2006) .
A lectin-based sandwich-type immunoassay was developed in order to compare the glycosylation patterns of human chorionic gonadotropin (hCG) hormone, and applied to urine specimens from patients presenting with normal pregnancy, invasive mole, choriocarcinoma, and male germ cell tumors (Kelly et al. 2007 ). GNA and MAA lectins, specific for terminal mannose and α-2,3-sialic acid, respectively, preferentially bind pregnancy-derived hCG. In contrast, the WGA lectin (with sialic acid and β-D-GlcNAc specificity) exhibited decreased binding to pregnancy-derived hCG as compared to patients with male germ cell tumors and malignant gestational trophoblastic neoplasia. The differential binding among these three lectins is encouraging and warrants the development of comparable assays for other glycosylated tumor markers (Kelly et al. 2007 ).
The glycosylation of urinary PSa from benign prostatic hyperplasia (BPH) and prostate cancer (PCA) were examined by analyzing the alterations of oligosaccharide chains as potential biomarkers for pathophysiological conditions. The urinary PSa of BPH and PCA patients were characterized by ion-exchange chromatography, followed by lectin affinity chromatography on immobilized UEA, AAA, PHA-E and PHA-L lectins. The observed differences in lectin reactivities between BPH PSa and PCA PSa may be of clinical importance for the evaluation of prostate condition (Jankovic & Kosanovic 2005) .
Conclusion
This review highlights the potential advantage of plant lectins as diagnostic tools in clinical medicine. The applications, based on lectin methodologies encompasses not only the ability to detect the biomarker (the glycosylated antigen), but also to separate and characterize the composition of the glycosylation patterns (Kre unin et al. 2007; Madera et al. 2007; Plavina et al. 2007; Wuhrer et al. 2007; Xu et al. 2007 ). Numerous diseases progress through several stages, which are accompanied by changes in glycosylation. These changes can be detected by lectin-tests, thus providing disease stage specific diagnostic tools. These can be further modified to predict responsiveness to treatment, prognosis and survival (Laack et al. 2002; Schumacher et al. 2005; Thom et al. 2007 ). Additionally, lectin-based diagnostic methods can be utilized in comparative studies of healthy and pathogenic specimens under normal conditions (Krzeslak et al. 2003; Kotani et al. 2004; Krotkiewska et al. 2005; Tabares et al. 2006) .
Currently, antibody-related diagnostics are the preferred method for monitoring glycosylation changes in ordinary biomedical laboratories. The major argument for antibodies instead of lectin-based diagnostic tools is the high specificity of antibodies for their interaction with glyco-antigen, independently on environment and laboratory techniques involved. The cons against antibody-based assays are the expense and long preparation times for antibodies, including their isolation and purification steps. The use of plant lectins instead of, or in conjunction with antibodies could speed up this process. Several hundreds lectins are available commercially, and these exhibit better stability in standard conditions, when compared to monoclonal antibodies. Additionally, lectins are attractive reagents for clinical laboratory diagnostics because of their diverse specificity and wide range of molecular weights. However, the detection of specific carbohydrate groups by non-covalent lectin binding is complicated by the lack of absolute specificity -lectins can bind number of similar carbohydrates, albeit with different affinities. Thus, the statistical reliability of lectins in diagnostics might be achieved by a combination of different tools and techniques. In general, it is possible to characterize the evolution of glycoconjugates on pathological cells with a panel of lectins, although a combination of lectins with monoclonal antibodies could be used in order to gain complete information about the antigenic repertoire of the diseased cells.
Lectinology, with the advent of better analytical techniques for glycoconjugates determination might undergo new revival (Schulz et al. 2007) . There are at least two lectin-based diagnostic methods with a promising perspective: multi-lectin affinity chromatography coupled with mass spectrometry and lectin microarray method, discussed in details elsewhere (Gemeiner et al. 2008) .
Mass spectrometry is a very useful tool for glycome characterization, collecting large sets of data within a single experiment and allowing structural description of glycans. Recently, lectin-affinity separation followed by tandem mass spectrometry were used to identify glycoproteins in human urine and serum , in human plasma (Plavina et al. 2007 ) and Nlinked glycoproteins from liver cells (Xu et al. 2007 ). Additionally, same approach was used to detect bladder cancer in urine samples (Kreunin et al. 2007 ). These methods can facilitate a more focused analysis of clinically relevant samples, which in turn will lead to the identification of reliable biomarkers for improved detection, surveillance and screening regimens for a range of diseases. Lectin-related diagnostics can become thus important methodology tools for personalized medicine.
Lectin microarray glycoanalysis is a novel, rapid and sensitive method based on a technology consisting of arrays of lectins with overlapping specificities. Binding of fluorescently labeled intact glycoprotein to the array of lectins in the microplates results in a characteristic fingerprint that is highly sensitive for changes in glycan composition of proteins. The large number of lectins (from nine to forty), each with a specific recognition domain, ensures high sensitivity to changes in the glycosylation pattern. The critical advantage over other methods is that it enables the detection of relatively weak lectin-oligosaccharide interactions, even in mixed samples (Pilobello et al. 2005; Ebe et al. 2006; Rosenfeld et al. 2007 ). Lectin microarray is a useful tool for life-science researchers of various disciplines and has potential for the diagnosis of diseases accompanied by glycosylation changes. The combination of the two above mentioned methods, i.e., lectin affinity chromatography followed by lectin microarray assays were used to differentiate pancreatic diseases (cancer or chronic pancreatitis) (Zhao et al. 2007b) .
As already mentioned, there are not too many tools available for direct differentiation of carbohydrates involved in intercellular interactions (Hyun et al. 2007 ). Artificial lectins are powerful molecules bringing in the requested specificity allowing thus more detailed analysis of saccharide chains. Artificial lectins with distinct and desired carbohydrate-binding specificities are produced by expression of altered DNA sequence from natural lectins in bacterial cells (Yamamoto et al. 2000; Stancombe et al. 2003; Hatakeyama et al. 2004; ) . The specificities displayed by artificial lectins exceed those of natural lectins. This suggests, that they can serve as useful and specific tools to detect changes in the terminal monosaccharide of cell-surface carbohydrates (Zhao et al. 2007b) . The ability to produce custommade lectins in a over-expression system (i.e. bacterial cells) is a novel trend in lectinomics and will expand the biomedical scope of lectins (Hyun et al. 2007) .
Additional possibilities of lectin applications are emerging in clinical medicine, besides the usefulness of plant lectins in disease diagnostic. The determination of sialic acids in order to monitor control of life span of human erythrocytes (Bratosin et al. 1995; Marikovsky & Marikovsky 2002) , or detection of multidrug resistance in cancer cells (Greer & Ivey 2007) , accompanied by the formation of P-glycoprotein illustrate these trends. Plant lectins-related drug delivery strategies compose another field of growing interest. WGA, among other significant drug-delivery examples was recently demonstrated to have promising features for targeting drugs into bladder cancer cells (Plattner et al. 2008) . Such functionalized molecules might find their way also into the field of lectin-based custom drug design in addition to lectin-based diagnostics.
